Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Radomized Trial of Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in the Treatment of Women With Metastatic Breast Cancer

NCT00002953 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00002953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Radomized Trial of Epirubicin & Cyclophosphamide vs. Epirubicin & Paclitaxel in the Treatment of Women With Metastatic Breast Cancer
Lead sponsor
Medical Research Council
Phase
Phase 3
Overall status
Completed
Start date
December 31, 1996
Completion date
November 30, 2005
Enrollment
704 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer